NVNO
enVVeno Medical Corporation
NASDAQ · Healthcare · Medical - Devices · US
$11.32
+2.01%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.8x
Market Cap
$7.87M
MomentumView details →
1D Return
+2.01%
YTD Return
+0.70%
RSI (14)
55.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.8x
Market Cap
$7.87M
RSI (14)
55.6
MomentumView details →
1D Return
+2.01%
YTD Return
+0.70%
SummaryUpdated Jun 1, 2026
enVVeno Medical Corporation (NASDAQ:NVNO) is a medical device company founded in 1999 and based in Irvine, California. Originally incorporated as Hancock Jaffe Laboratories, Inc., the company rebranded to enVVeno Medical Corporation in October 2021 to better reflect its focus on venous disease treatment solutions. The company went public in May 2018 and specializes in developing bioprosthetic tissue-based medical devices designed to improve treatment standards for patients suffering from venous diseases.
Similar companies
Latest newsMore news →
ENVVENO MEDICAL CORP filed a mixed shelf registration statement to offer up to $100 million in securities.14d agoenVVeno Medical highlighted the publication of a peer-reviewed health economic study in the Journal of Vascular Surgery: Venous and Lymphatic Disorders demonstrating the cost-effectiveness of its enVVe replacement venous valve therapy versus standard of care for deep venous chronic venous insufficiency.31d agoenVVeno Medical received FDA IDE approval to begin the TAVVE pivotal trial for its enVVe System, a first-in-class minimally invasive replacement venous valve.35d ago